Royal Bank of Canada’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Royal Bank of Canada’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-240	Closed	-$3K	–	7900
2023 Q3	$3K	Buy	240 +217	+943%	+$1.71K	﹤0.01%	6754
2023 Q2	$0	Buy	+23	New	+$216	﹤0.01%	7880
2021 Q3	–	Sell	-184	Closed	-$18K	–	7982
2021 Q2	$18K	Buy	184 +123	+202%	+$12.2K	﹤0.01%	6627
2021 Q1	$7K	Buy	61 +25	+69%	+$3.53K	﹤0.01%	6966
2020 Q4	$5K	Buy	+36	New	+$4.63K	﹤0.01%	6677
2020 Q3	–	Sell	-1	Closed	–	–	7053
2020 Q2	$0	Sell	1 -65	-98%	-$7.95K	﹤0.01%	7012
2020 Q1	$6K	Buy	66 +50	+313%	+$5.13K	﹤0.01%	6003
2019 Q4	$2K	Buy	+16	New	+$1.76K	﹤0.01%	6590

Other funds holding AXLA

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Royal Bank of Canada's AXLA Position: Q4 2023 in Review

Royal Bank of Canada sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 240 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in AXLA in Q4 2019 and held it in 8 quarters. The position peaked at $18K in Q2 2021. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.

Royal Bank of Canada reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Royal Bank of Canada sold 240 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $3K.
Royal Bank of Canada first reported a position in Axcella Health Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Royal Bank of Canada's Axcella Health Inc. Common Stock position peaked at $18K in Q2 2021.
1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.